Efficacy and Safety of Admilparant, an LPA₁ Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial

Authors: Tamera J. Corte, Juergen Behr, Vincent Cottin, Marilyn K. Glassberg, Michael Kreuter, Fernando J. Martinez, Takashi Ogura, Takafumi Suda, Marlies Wijsenbeek, Elchonon Berkowitz, Brandon Elpers, Sinae Kim, Hideaki Watanabe, Aryeh Fischer, Toby M. Maher

Published: 2024-10-11

DOI: 10.1164/rccm.202405-0977oc

Source: Full article

---

Abstract

No abstract found.